title: [Cystectomy in superficial bladder tumours. Analysis of criterion include and prediction factors].
abstract: BACKGROUND
  Though usually the treatment of a superficial bladder tumour consists in transurethral resection, exceptionally because of several clinical conditions, in this kind of patients a radical cystectomy may be suitable.
  
  
  METHODS
  From june 1986 through december 2001, 127 radical cystectomies were performed. A series of 25 patients with a radical cystectomy performed in superficial bladder tumours were analysed. Indications, anatomo-pathological correlation and clinical evolution with survival curves are analysed.
  
  
  RESULTS
  The mean time of follow-up was 47 months. Extensive GIIIpT1 tumours (40%) were the chief indication. The remaining of the series consisted in carcinoma uncontrollable by endoscopy and refractory to chemotherapy. Anatomo-pathological correlation coincided in 48% of patients, existing supra and understaging in 25% and 28% respectively. A period of 54 months was without relapse. Seven patients died during the evolution (28%), and 18 patients are alive without disease. 128,48 months were the mean actuarial survival.
  
  
  CONCLUSIONS
  GIIIpT1 tumours were the chief indication of our series. The significant percentage of understaging, poor morbidity and good survival curves are emphasized. Because of these results we consider that radical cystectomies are a viable choice for selected patients with superficial vesical tumour.
authors.affiliation: Servicio y Cátedra de Urología, Hospital del Mar, UAB, Barcelona.
authors.forename: N
authors.initials: N
authors.lastname: Alonso Gracia
authors.forename: J A
authors.initials: JA
authors.lastname: Lorente Garín
authors.forename: E
authors.initials: E
authors.lastname: de León Morales
authors.forename: D
authors.initials: D
authors.lastname: Cañís Sánchez
authors.forename: O
authors.initials: O
authors.lastname: Bielsa Galí
authors.forename: A
authors.initials: A
authors.lastname: Gelabert-Mas
mesh_terms: D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000473:pathology* / Q000601:surgery*; D015653:Cystectomy / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000601:surgery*